The unaudited financial Results of the company for the quarter ended 30th June 2025 along with the limited review report of the auditors thereon.
Awaiting price reaction for this filing.
Soni Medicare Ltd reported Q1 FY26 revenue from operations of Rs. 727.71 lakhs, up about 2.7% year-on-year from Rs. 708.27 lakhs. Total income stood at Rs. 749.20 lakhs versus Rs. 727.84 lakhs in the same quarter last year. The company continued to post a net loss of Rs. 29.10 lakhs, but this was a sharp improvement from the Rs. 86.63 lakh loss in Q1 FY25, helped by lower other expenses which fell to Rs. 346.28 lakhs from Rs. 430.57 lakhs. Loss per share narrowed to Rs. 0.68 from Rs. 2.03 a year ago. The auditor, Tambi Ashok & Associates, issued an unmodified (clean) limited review report with no qualifications or emphasis of matter.
While revenue growth is modest and the company remains loss-making at the bottom line, the significant YoY narrowing of losses and operating-level turnaround may be viewed positively by shareholders, though sustained profitability is still not visible. No negative audit flags were raised, which removes a key near-term risk.